Tag: dual GIP GLP-1 agonist

Posted on by

Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show

3D visualization of dual incretin peptide interacting with transmembrane cell receptors.

A comprehensive review of the clinical evidence for tirzepatide, examining glycemic and weight loss outcomes across the landmark SURPASS and SURMOUNT phase

Read more Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show

Posted on by

Tirzepatide in Metabolic Research: A Minto Pyramid Profile of Dual GIP/GLP-1 Receptor Agonism

3D molecular visualization of the dual GIP and GLP-1 receptor agonist peptide tirzepatide interacting with cell surface recep

A structured Minto Pyramid review examining tirzepatide’s pharmacology, evidence hierarchy, and dual GIP/GLP-1 receptor agonism in metabolic and endocrine

Read more Tirzepatide in Metabolic Research: A Minto Pyramid Profile of Dual GIP/GLP-1 Receptor Agonism